Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories Ltd has informed BSE that its Board of Directors will meet on Friday, 6th February 2026. The main agenda is to consider and approve the un-audited standalone financial results (under Ind AS) for the quarter and nine months ended 31st December 2025, i.e., the Q3 FY26 results. The trading window for designated persons has been closed from 1st January 2026 until 48 hours after the results are made public, in line with insider trading rules. No specific financial figures, guidance, or other business items have been disclosed in this notice.
This is a routine pre-results intimation with no new fundamental information. Investors should watch for the actual Q3 FY26 numbers expected on or shortly after 6th February 2026, which could move the stock depending on performance versus expectations.